Some people crave espressos or other caffeine-spiked drinks. Joining them in spirit is Pseudomonas putida CBB5, a soil bacterium that demethylates caffeine to xanthine. When its caffeinedegrading gene cluster is transferred into Escherichia coli, the latter bacteria act like a biosensor, measuring caffeine concentrations in beverages or other fluids, according to Jeffrey Barrick at the University of Texas, Austin, and his collaborators.
The caffeine-converting, nitrogen demethylation pathway in P. putida CBB5 contains four key genes-ndmA, ndmB, ndmC, and ndmD. Inserting them into E. coli, however, is not enough for the recipient to convert 7-methylxanthine effıciently to xanthine. Adding a glutathione S-transferase (GST) gene, which was identifıed through a database search, from another soil microbe, Janthinobacterium sp. Marseilles, signifıcantly boosts that effıciency, according to Barrick. "I'm continually amazed by the chemical abilities of microbes and how much is still unexplored in databases," he says.
Barrick describes this engineered E. coli as being addicted to caffeine, meaning it depends on caffeine-ranging from as little as 10 M up to 5 mM-for growth. This growth dependence can be used to estimate caffeine levels in drinks, he says. For example, caffeine-free cola drinks do not support growth, whereas commercially available espresso supports high growth. A diagnostic test based on microbial enzymes "could be used to mea-sure caffeine in pharmaceuticals, drinks, and mother's milk," says coauthor Mani Subramanian, director of the Center for Biocatalysis and Bioprocessing at the University of Iowa, Iowa City. For details, see the March 22, 2013 ACS Synthetic Biology (doi:10. 1021/sb4000146).
Companies are interested in possibly using such cells to develop a rapid test that consumers might use to measure drinks for caffeine, according to Subramanian. Others want to use microbes for synthesizing dimethyl and monomethyl xanthines, which are diffıcult-to-manufacture components of asthma and other medications. "It's easier to start with cheap caffeine and specifıcally remove methyl groups in the right place with demethylase genes," he says.
Another company is exploring the feasibility of using such microorganisms to decaffeinate tea and coffee, a potentially more environmentally friendly method than is the widely used methylene chloride-extraction process. Also, coffee bean processing produces nutrient-rich byproducts, but high levels of caffeine prevent their agricultural use. Caffeine-loving E. coli might be used to decaffeinate this waste and make it suitable for fertilizers, animal feed, or biofuels, according to Subramanian. "I'm surprised at the interest from companies wanting to try different industrial applications," he says. "Before this system is applied in the fıeld, the developers might want to integrate a backup kill switch to prevent any unchecked invasion of caffeinerich food stocks," says systems engi-Escherichia coli strains carrying genes from a caffeine-converting, nitrogen demethylation pathway in Pseudomonas putida CBB5 might welcome a strong cup of coffee, as they rely on caffeine for growth-and can be used as a basis for tests to measure caffeine levels, among other applications.
neer Karmella Haynes of Arizona State University in Tempe, referring to the genetically modifıed, caffeine-degrading strain of E. coli. Ideally, a kill switch targets only that microbe and can be readily activated. However, because such kill switches are prone to mutagenesis, "making a good kill switch is not a trivial task," she says.
Carol Potera is a freelance writer in Great Falls, Mont.
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Close Watch over Deadly H7N9, H5N1 Influenza Strains Jeffrey L. Fox
Although neither the H7N9 nor H5N1 strains of influenza virus is readily transmissible among humans, both strains are more deadly than seasonal flu and would pose huge public health challenges if either were to break through that transmissibility constraint, according to several leading influenza experts. Moreover, efforts to develop vaccines in advance of such a change are also raising concerns, particularly in the case of the H7N9 strain because it is not a particularly effective immunogen. These and other concerns were aired during the late-breaking session "Pandemic Threats from Emerging Avian Influenza Viruses, H7N9 and H5N1: Challenges for Public Health, Research, Surveillance and Countermeasures," convened during the 2013 ASM General Meeting last May in Denver.
The H5N1 flu strain, which appeared in 1997, was beaten back for several years when Hong Kong poultry markets were closed and flocks were culled, but then reappeared in 2004 and by now has spread throughout Asia, Europe, and Africa, but not the Americas, says Robert Webster of St. Jude's Research Hospital in Memphis, Tenn. In the decade leading up to 2013, H5N1 flu infections caused 350 deaths in 630 human cases, about a 60% fatality rate, according to Albert Osterhaus of Erasmus University Medical Center in Rot-terdam, the Netherlands. The H5N1 strain also causes lethal illnesses in chickens and turkeys, and a prime reservoir for this virus is aquatic ducks.
Meanwhile, the more recently emergent H7N9 strain caused its fırst two fatal human cases in February of this year, and continues to expand in scope (Microbe, June 2013, p. 235), according to Webster. Through June, H7N9 caused at least 43 deaths among 133 human cases, most of them in eastern China. It infects mainly those who are older than 60, predominantly men, he says. Poultry is the "most likely" source of these H7N9 infections in humans, but that presumed transmission pathway is "still not certain," adds Osterhaus. Unlike H5N1, the H7N9 flu strain causes few, if any, symptoms in infected birds.
"Neither H5N1 nor H7N9 is transmitted from human to human, but H5N1 mutants can transfer between ferrets," Webster says. However, Osterhaus points out, H7N9 now carries three of the fıve mutations that are associated with H5N1's transmissibility in that mammalian species. It (H7N9), too, "may be close to transmissibility." (See minitopic, p. 308.) Unlike seasonal flu, which stays mainly within the upper respiratory system, H5N1 "gives a systemic infection and a lot of pathology," Osterhaus says. "With H7N9 in the ferret, what we see in the lungs is comparable to H5N1, where it is quite serious with a lot of pathology." Although the pandemic threat for either one of these strains "can't be estimated," if one or the other were to become pandemic, "it will be devastating."
Amid these concerns, efforts are under way to generate "seed" strains for making vaccines to protect against the H7N9 flu strain, according to Carol Heilman of the National Institute of Allergy and Infectious Diseases (NIAID) at NIH in Bethesda, Md. One big problem, "H7 is a lousy immunogen," she says. Because of that diffıculty, it might well require double dos-ing and possibly also an adjuvant to induce protective immunity among recipients of such a vaccine. "It would be MINITOPIC
U.S., Other National Science Academies Highlight Drug Resistance
The U.S. National Academy of Sciences (NAS) in Washington joined with 12 other national science academies last May in issuing several statements to inform world leaders on key science issues. One such statement provides recommendations for combating antibiotic resistance, including through better global surveillance, more responsible use of anti-infective drugs, enhanced prevention of infection, discovery of new drugs, and through enhancing developing countries to be partners in the fight against emerging antimicrobial drug resistance. "Our aim in making these recommendations is threefold," the NAS and other academies note. "First, we wish to draw increased attention of the world to this growing problem. Second, we hope to encourage the G20 [economically developed] countries to place the problem of combating the emergence and spread of drug-resistant infectious agents high on their health agenda. . . . And third, we would like the international community to find ways and means to encourage pharmaceutical companies to invest in the development of novel anti-infective drugs in general, but especially antibiotics." Science academies of Canada, France, Germany, India, Italy, Japan, Malaysia, Mexico, Nepal, Russia, South Africa, the United Kingdom, the United States, and the regional African Academy of Sciences signed this statement.
a big hurdle to overcome if we have to use an adjuvant," she adds. For U.S. vaccines, several effective adjuvants are "stockpiled but not yet licensed." Jeffrey L. Fox is the Microbe Current Topics and Features Editor.
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Database Tracks, Codifies Dynamics of Antibiotic Resistance David C. Holzman
The journals are awash with evidence of expanding antibiotic resistance. To help deal with that flood, Gerard D. Wright of McMaster University in Hamilton, Ontario, Canada, and his collaborators assembled what they call the Comprehensive Antibiotic Resistance Database (CARD). "We now have a one-stop shopping resource for genomic, biological, and phenotype data for the fıeld of antibiotics," he says. Details appeared online May 6, 2013, in Antimicrobial Agents and Chemotherapy.
CARD is a dynamic entity, according to Wright. "We encourage people to help add data and expand the work," he says. "That way it becomes a tool for the whole community, and not just for my lab." One of the tools, the Resistance Gene Identifıer, allows researchers to upload or paste their data or information from another database, and have the CARD identify and classify the resistance genes on the Web.
Many things account for the scope of this information-assembly challenge. Resistance mechanisms are plentiful, and there are "hundreds if not thousands of organisms, species, and individual isolates," to keep track of, according to the report. "This is in addition to associated genetic elements such as plasmids, transposons, and integrons that provide individual organisms with additional genetic information often associated with pathogenesis and antibiotic resistance." "Surveys of genes originating from both clinical and environmental sources will provide increasing insight into reservoirs and offer predictive capacity for the emergence and epidemiology of antibiotic resistance," Wright notes. For example, had it been available, CARD could have helped to track the early spread of gram-negative bacteria carrying the gene encoding the now-notorious New Delhi metallo-␤lactamase (NDM-1), an enzyme that enables such bacteria to hydrolyze virtually all ␤-lactam antibiotics, except monobactams. This recent case "illustrates the capacity of new antibiotic resistance genes to emerge rapidly from as-yet-undetermined reservoirs," he and his collaborators point out.
"The fact that [CARD] will be managed with full public access is highly commendable," says Karen Bush of Indiana University in Bloomington. "However, it is not clear how the problems associated with redundant naming of resistance-related genes or proteins will be handled." Another uncertainty involves "the linkage between clinical resistance and the sum of all the resistance determinants in a single organism," she adds. "Few laboratories search for every possible resistance determinant in an organism, so that conclusions regarding the cause for an observed phenotype may not be completely answered by a search of this database." CARD works by "defıning an antibiotic resistance ontology that is essential for clear communication and consistent nomenclature about the antibiotic resistance present in microbial com-
MINITOPIC
Recent Developments Involving Emergent Influenza Strains
Recent developments involving emergent strains of the influenza virus include:
• The H7N9 influenza virus, which began infecting humans in China early this year, can infect ferrets and is transmitted between such animals; it also can infect pigs but is not transmitted between them, according to Y. munities," says Gautam Dantas of Washington University in St. Louis, Mo., who was not involved in developing CARD. The new database provides an "extremely useful" boost to the specifıcity of resistance gene functional annotation, he says, noting that "the general nomenclature of resistance genes in public databases is often vague, and many times misleading." A direct benefıt is the ability to use DNA sequence data from clinical samples to improve predictions of antibiotic susceptibility profıles, which would lead to "more prudent antibiotic treatments." David C. Holzman is the Microbe Journal Highlights Editor
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Dispute Flares over Bacteria in Packaged Ground Turkey Barry E. DiGregorio
Ground turkey from U.S. supermarkets frequently contains fecal-associated bacteria, including Escherichia coli and Enterococcus spp., and occasionally frank pathogens such as methi-cillin-resistant Staphylococcus aureus (MRSA), according to Urvashi Rangan and her collaborators of Consumers Union of Yonkers, N.Y. Some of these bacteria carry genes conferring resistance to antibiotics, they report. However, turkey producers dispute those fındings and their importance for consumers of these meat products.
Last year, Rangan and her collaborators analyzed packages of ground turkey from food markets in 21 states. Among their fındings, 69% of such samples contained Enterococcus and 60% harbored E. coli, consistent with fecal contamination. About 80% of the enterococcal isolates were resistant to three or more types of antibiotics, as were more than half the E. coli isolates. Details appear in the June 2013 Consumer Reports (CR) (http://www.con sumerreports.org/turkey0613?buffer_ shareϭ18bb5&utm_sourceϭbuffer &utm_mediumϭtwitter&utm_cam paignϭBuffer%253A%252Bbittman %252Bon%252Btwitter#).
Poultry producer groups as well as food safety experts contest the fındings and their health importance. For ex-
Packages of ground turkey recalled in 2011 due to Salmonella contamination. A recent article in
Consumer Reports on contamination in ground turkey drew criticism from poultry producers and food safety. (AP Photo/Paul Sakuma.)
MINITOPIC
Some Odd Intersects between History and Microbiology
Here are several recent examples in which history and microbiology intersect in noteworthy ways:
• A strain called HERB-1, not the ample, the National Turkey Federation (NTF) calls the fındings "misleading" and says the CR report contains "a number of alarming claims based on an extremely small sampling of ground turkey products." The NTF "response captures our point of view as well," says Rafael E. Rivera of the U.S. Poultry & Egg Association.
For example, although the CR report says that ground turkey contains high levels of bacteria, "the two most prevalent, Enterococcus and generic E. coli, are not considered sources of foodborne illness," NTF notes. Moreover, the CR report is "misleading" about MRSA bacteria, which are "ubiquitous in the environment, and are even present on our hands and in our bodies," and also about "antibiotic resistance traits in the samples."
"We found that resistance was higher for antibiotic classes approved for use in turkey production compared to antibiotic classes that were not approved for turkey production," Rangan says. "More than half of all the diseasecausing organisms we found were resistant to three or more antibiotics used in human medicine.
"All of the organisms we studied can be disease-causing organisms," Rangan continues. "Enterococcus, for example, is associated with skin and blood and also urinary tract infections." Although Salmonella turned up less frequently in the samples, more than 403 million pounds of ground turkey are being produced annually, she points out, citing data from NTF. "Given that the Cargill recall in 2011 was approximately 36 million pounds of ground turkey contaminated with Salmonella, we think there is cause for concern and better cleanup." "I would say the CR report is not scientifıcally based in its interpretation of its results," says Michael Doyle, Director for the Center for Food Safety at the University of Georgia. "It's the way CR is interpreting the results that is misrepresenting science. I think it is really going to affect the credibility of consumer science when they put out things out like this." "We are focused on what the consumer experience is in the marketplace, and we may call for stronger regulations on behalf of consumers if we believe it would be more protective of public health," says Jen Shecter of CR. "The results of our study are consistent with what the government National Antimicrobial Resistance Monitoring System retail meat program fınds." Barry E. DiGregorio is a freelance writer in Middleport, N.Y.
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Men and Women Respond Differently to Some Viruses, Vaccines Shannon Weiman
Estrogen and other sex hormones put women at greater risk than men in their responses to some viral infections and vaccines, according to several participants who spoke during the symposium "Men, Women, Infection, and Infertility," convened as part of the 2013 ASM General Meeting last May in Denver. While heightened immune responses make women typically less susceptible than men to many bacterial and viral infections, those heightened immune responses sometimes prove damaging.
For example, once infected by HIV and despite their viral loads remaining relatively lower, women tend to progress to AIDS faster than do men, says Marcus Altfeld of the Ragon Institute of Massachusetts General Hospital in Boston, Mass. This difference is due, in part, to how the hormones estrogen and progesterone affect innate immune responses. These two hormones, which circulate in women but not in men, induce higher levels of the Tolllike receptor (TLR) 7 as well as a specifıc signal transducer molecule that contributes toTLR7 activation, he says. TLR7 detects single-stranded viral RNA and initiates immune responses to such viruses.
"Plasma dendritic cells derived from women produce twice as much interferon ␥ (IFN-␣) in response to TLR7, resulting in stronger secondary activation of CD8ϩ T cells," Altfeld continues. Ultimately, increased IFN-␣ production in females drives cytotoxic T cells to destroy CD4 cells, enabling the disease to progress more rapidly. Thus, he suggests targeting TLR7 in women to slow HIV and possibly other RNA viruses with similar gender-specifıc effects. Such antagonists are in development for treating autoimmune disorders such as lupus, which are TLR7
MINITOPIC
Ongoing Debate over White House Mandated Access to Research
The White House issued an executive order in May requiring government information to be "open," extending plans from earlier this year to increase access to federally sponsored research findings. For example, findings from health-related research that is supported by the National Institutes of Health (NIH) are supposed to be "deposited" in PubMed Central (PMC), and some experts believe that this practice should be broadened to include all federally supported research of this type. NIH officials said that they will begin to delay funding of grants for those researchers who fail to send relevant publications to PMC. However, not everyone agrees with this approach to broadening access. The Genetics Society of America, for instance, says that it and other similar publishers in the private sector "are in the best position to carry out these objectives, all at low cost. Indeed, most publishers have already developed a robust infrastructure to provide these and other objectives." dependent and overrepresented in women.
Women are also more susceptible than men to influenza, according to Sabra Klein of Johns Hopkins Bloomberg School of Public Health in Baltimore. Estrogen accentuates inflammatory responses and promotes immunopathology, she says. "Titers of infectious virus in the lungs do not differ between the sexes . . . (but) females show greater induction of cytokines and chemokines, including chemokine ligand (CCL)-2, tumor necrosis factor ␣ (TNF-␣), IFN-␥, and interleukin 6." Influenza induces inflammation in females by disrupting the estrous cycle when estrogen is at its low. At low concentrations estrogen promotes inflammation, whereas at higher concentrations estrogen suppresses inflammation and promotes the T-helper (Th) 2 response. Moreover, in experiments with mice, treating influenza-infected females with estrogen protects them against morbidity and mortality by suppressing inflammatory responses, Klein and her collaborators fınd.
Together these fındings suggest that gender should be taken into account when designing vaccines, according to Klein. Some vaccines act through TLR7, including the yellow fever vaccine. "Antibody responses to bacterial and viral vaccines are consistently at least twice as high in women," she says. Moreover, she adds, a heightened immune response, and unnecessarily high dosing, may help to explain why women report more frequent and severe adverse reactions to vaccines than do men. This difference might explain why a vaccine to protect against the herpes simplex virus failed to show protection after phase 2 clinical trials.
"When data were analyzed by sex, the effıcacy of the vaccine was 73% in women and only 11% in men," she says.
Shannon Weiman is a freelance writer in San Francisco, Calif.
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Kids with Recurrent Infections: No Spleen, Defective Ribosomes
Jeffrey L. Fox "This is the fırst time I was invited to ASM," says Jean-Laurent Casanova of the Rockefeller University in New York, N.Y. Although a pediatrician and geneticist, not a microbiologist, he recently deduced why some children are highly susceptible to invasive pneumococcal disease (IPD). That is, they are vulnerable to this specifıc type of lifethreatening infectious disease, but otherwise are immunocompetent. He spoke during the plenary session, "Bedside to Bench: Microbiology in the Clinics," convened during the 2013 ASM General Meeting last May in Denver.
IPD is a very rare condition, affecting perhaps 1 in 1,000 individuals, about two-thirds of whom die from such infections, according to Casanova. Even though this vulnerability to IPD infections proves so often deadly, the medical condition did not attract all that much attention from immunologists and microbiologists, he says. Part of the reason is that the availability of antibiotics enables some children with IPD (or other conditions leading to singular infections) to survive-in a sense masking the subtleties of what truly is wrong. Further, children with broad immunodefıciencies are lumped into one group, and then analyzed in terms of the genetic traits that could account for one or another specifıc but generalized immunodefıciency. Meanwhile, children with IPD or other susceptibilities to single infectious diseases are considered "immunocompetent" and thus do not attract in-depth analysis, he adds, "and that's how the fıeld took shape."
Children with IPD are born without spleens but have no other obvious developmental defects, according to Casanova and his collaborators. Precisely why missing their spleens renders such children specifıcally vulnerable to IPD is not known, leaving an important part of this medical mystery unresolved, he says. However, he adds, "We identifıed the gene that explains why some children are born without spleens."
In its early stages, that genetic analysis involved "excluding thousands of mutations," next "working down to 4,000 genes," and then determining that the human ribosomal protein SA (RPSA) gene "showed up as signifıcant and all patients [missing spleens] carried RSPA mutations," Casanova continues. "These data show that the mutation for RPSA is causal."
Pinpointing RPSA as causal leads to the "riddle of how it's associated with asplenia," Casanova continues. "RPSA is part of the small ribosomal subunit, and it's our hypothesis that the ribosome is not a blind machine. We make the case for the ribosome contributing to gene expression in an epigenetic manner." Thus, he and his collaborators argue that ribosomes carrying this mutant protein somehow "can't process the messenger RNAs that are needed for constructing the spleen." safe-for-humans protein family which includes proteins used as pesticides in organic farming, and in genetically engineered, pest resistant crops. The team expressed Cry5B in Bacillus subtilis, which is closely related to bacteria used in some probiotics and food products. It achieved a 93% elimination of hookworm parasites from infected hamsters, far superior to existing drugs in terms of molarity. 
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Antibiotic Reduction Campaigns Do Not Necessarily Reduce Resistance: It's Complicated!
Antibiotic use-and misuse-is the main driver for selection of antibiotic-resistant bacteria. This has led many countries to implement interventions designed to reduce overall antibiotic consumption. Such a program in France reduced use by 10% in 2002-2003. Now using a mathematical model of MRSA circulation, which correctly simulated that reduction, Laura Temime of the Conserva-toire National des Arts et Metiers, Paris, and collaborators fınd that reductions of antibiotic use don't necessarily lead to a decrease in resistance. Targeting specifıc classes of antibiotics is necessary to maximize the impact of these reductions on the burden of resistance. The reason, says Temime, is that in the case of MRSA, some antibiotics, such as clindamycin and methicillin, select for resistance more strongly than others. Further, it is necessary to coordinate actions in different settings-e.g., the hospital and the community-in order to insure that these efforts are synergistic, rather than canceling each other out, says Temime.
(L. Kardas-Sloma, P.-Y. Boelle, L. Opatowski, D. Guillemot, and L. Temime. 2013 . Antibiotic reduction campaigns do not necessarily decrease bacterial resistance: the example of methicillin-resistant S. aureus. Antimicrob. Agents Chemother. Online ahead of print 1 July 2013; doi:10.1128/AAC.00711-13)
JOURNAL OF VIROLOGY
New Insights on Cancer/DNA Virus Associations Could Help Personalize Treatments
It has long been established that some cancers are caused by DNA viruses. Now, for the fırst time, Xiaoping Su and colleagues of the MD Anderson Cancer Center, Houston, Tex., have used RNA sequencing to search for DNA virus associations within 3,775 human malignancies from The Cancer Genome Atlas (TCGA), which they then analyzed using a robust bioinformatics algorithm. A surprising number of cancers, many of them common, were found unassociated with DNA virus, including acute myeloid leukemia; cutaneous melanoma; low-and highgrade gliomas of the brain; and adenocarcinomas of the breast, colon and rectum, lung, prostate, ovaries, kidneys, and thyroid. The study provides a framework for unbiased understanding of how viruses integrate into cancer subtypes such as hepatocellular cancer, which might enable personalized treatments, says Su, "by targeting genes that are located within known integration sites and that might be drivers of cancer initiation and progression." A key fınding, he adds, was that there are specifıc sites, frequently located within particular host genes, where viruses integrate into the host genome prior to initiating cancer.
